Allergan Draws Arms against Indian Generic Companies over Patent Infringement
shot by IP News Shots / 6:32 pm on 27 July, 2021
Allergan USA Inc. has filed four patent infringement cases at the US District Court for the District of Delaware against generic companies from India accusing them of infringing on a Viberzi patent with their proposed generics. The defendants include MSN Laboratories Pvt. Ltd., Hetero Labs Ltd., Aurobindo Pharma Ltd., Sun Pharmaceutical Industries Ltd. and Zydus Pharmaceuticals (USA) Inc. They have been accused of seeking approval for generics of Allergan’s irritable bowel syndrome drug which infringe on the company’s patent.
Read more at Law360